previous studies have suggested that probiotic administration may have therapeutic andor preventive effects on atopic dermatitis in infants however its role in allergic airway diseases remains controversialto determine whether daily supplementation with specific lactobacillus gasseri a5 for 8 weeks can improve the clinical symptoms and immunoregulatory changes in school children suffering from asthma and allergic rhinitis arwe conducted a randomized doubleblind placebocontrolled study on school children age 612 years with asthma and arthe eligible study subjects received either l gasseri a5 n  49 or a placebo n  56 daily for 2 monthspulmonary function tests were performed and the clinical severity of asthma and ar was evaluated by the attending physicians in the study perioddiary cards with records of the day and nighttime peak expiratory flow rates pefr symptoms of asthma and ar scores of the patients were used for measuring the outcome of the treatmentimmunological parameters such as the total ige and cytokine production by the peripheral blood mononuclear cells pbmcs were determined before and after the probiotic treatmentsour results showed the pulmonary function and pefr increased significantly and the clinical symptom scores for asthma and ar decreased in the probiotictreated patients as compared to the controlsfurther there was a significant reduction in the tnfα ifnγ il12 and il13 production by the pbmcs following the probiotic treatmentin conclusion probiotic supplementation may have clinical benefits for school children suffering from allergic airway diseases such as asthma and ar